X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs UNICHEM LAB - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD UNICHEM LAB STRIDES SHASUN LTD/
UNICHEM LAB
 
P/E (TTM) x 32.4 -280.6 - View Chart
P/BV x 0.9 2.1 41.8% View Chart
Dividend Yield % 1.1 1.2 92.5%  

Financials

 STRIDES SHASUN LTD   UNICHEM LAB
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
UNICHEM LAB
Mar-17
STRIDES SHASUN LTD/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,275320 398.5%   
Low Rs918221 415.4%   
Sales per share (Unadj.) Rs389.6167.2 233.0%  
Earnings per share (Unadj.) Rs28.012.0 233.9%  
Cash flow per share (Unadj.) Rs48.916.9 288.8%  
Dividends per share (Unadj.) Rs4.503.00 150.0%  
Dividend yield (eoy) %0.41.1 37.0%  
Book value per share (Unadj.) Rs303.1117.0 259.0%  
Shares outstanding (eoy) m89.4290.88 98.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.6 174.0%   
Avg P/E ratio x39.222.6 173.3%  
P/CF ratio (eoy) x22.416.0 140.4%  
Price / Book Value ratio x3.62.3 156.5%  
Dividend payout %16.125.1 64.1%   
Avg Mkt Cap Rs m98,03624,578 398.9%   
No. of employees `0005.85.2 111.8%   
Total wages/salary Rs m5,8812,487 236.4%   
Avg. sales/employee Rs Th6,005.92,928.3 205.1%   
Avg. wages/employee Rs Th1,014.0479.4 211.5%   
Avg. net profit/employee Rs Th431.2209.4 205.9%   
INCOME DATA
Net Sales Rs m34,83415,195 229.2%  
Other income Rs m1,686110 1,529.8%   
Total revenues Rs m36,52015,305 238.6%   
Gross profit Rs m6,4281,788 359.5%  
Depreciation Rs m1,872452 414.2%   
Interest Rs m2,26934 6,733.8%   
Profit before tax Rs m3,9731,413 281.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470326 144.3%   
Profit after tax Rs m2,5011,087 230.1%  
Gross profit margin %18.511.8 156.8%  
Effective tax rate %11.823.1 51.3%   
Net profit margin %7.27.2 100.4%  
BALANCE SHEET DATA
Current assets Rs m38,1656,426 593.9%   
Current liabilities Rs m30,4023,917 776.1%   
Net working cap to sales %22.316.5 135.0%  
Current ratio x1.31.6 76.5%  
Inventory Days Days7768 114.3%  
Debtors Days Days10477 135.7%  
Net fixed assets Rs m37,6397,410 508.0%   
Share capital Rs m894182 491.9%   
"Free" reserves Rs m26,21010,454 250.7%   
Net worth Rs m27,10510,636 254.8%   
Long term debt Rs m16,3774 372,206.8%   
Total assets Rs m81,16815,258 532.0%  
Interest coverage x2.842.9 6.4%   
Debt to equity ratio x0.60 146,059.4%  
Sales to assets ratio x0.41.0 43.1%   
Return on assets %5.97.3 80.0%  
Return on equity %9.210.2 90.3%  
Return on capital %12.113.6 88.7%  
Exports to sales %024.1 0.0%   
Imports to sales %04.9 0.0%   
Exports (fob) Rs mNA3,666 0.0%   
Imports (cif) Rs mNA752 0.0%   
Fx inflow Rs m13,4655,298 254.1%   
Fx outflow Rs m4,0760-   
Net fx Rs m9,3895,298 177.2%   
CASH FLOW
From Operations Rs m2,881683 421.6%  
From Investments Rs m-7,051-1,316 536.0%  
From Financial Activity Rs m3,382592 571.1%  
Net Cashflow Rs m-788-40 1,973.8%  

Share Holding

Indian Promoters % 27.7 50.1 55.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 15.1 250.3%  
FIIs % 8.6 3.0 286.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 31.7 81.7%  
Shareholders   56,241 20,176 278.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Analysis of IPOs Launched in 2018, Governments Effort to Boost Aviation Infrastructure and Key Stocks in Action Today(Pre-Open)

The returns from initial public offers (IPOs) launched in 2018 are mixed. Comparing the gain/ (loss) since the listing date as mentioned in the last column, seven stocks are in the negative territory.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jun 21, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS